RX Drugnews homepage



  • Treanda bendamustine - Cephalon, Inc

    Treanda: Adult Dosing

    Dosage forms: IV
    chemotherapy
    uses, dosing may vary
    Info: for all uses, refer to institution protocols and pkg insert prior to prescribing; see pkg insert for toxicity-related dose adjustments
    CLL
    100 mg/m^2 IV qd x2 doses
    Info: 28-day cycle, may repeat for up to 6 cycles
    renal dosing
    see below
    mild-mod impairment: caution advised; CrCl <40: avoid use
    hepatic dosing
    see below
    mild impairment: caution advised; AST or ALT 2.5-10x ULN and billirubin 1.5-3x ULN, or bilirubin >3x ULN: avoid use

    Treanda: Peds Dosing

    This information is currently unavailable or not applicable for this drug.

    Treanda: Contraindications/Cautions

    • hypersens. to drug/class/compon.
    • hypersens. to mannitol
    • caution if myelosuppression

    Treanda: Adverse Reactions

    Serious Reactions
    • myelosuppression
    • neutropenia
    • thrombocytopenia
    • anemia
    • leukopenia
    • lymphopenia
    • febrile neutropenia
    • pneumonia
    • sepsis
    • anaphylactic/anaphylactoid rxns (rare)
    • tumor lysis syndrome
    • skin toxicity, severe
    • bullous exanthema
    Common Reactions
    • myelosuppression
    • neutropenia
    • thrombocytopenia
    • anemia
    • leukopenia
    • fever
    • nausea/vomiting
    • diarrhea
    • fatigue
    • asthenia
    • rash
    • hyperuricemia
    • weight loss
    • lymphopenia
    • nasopharyngitis
    • chills
    • infection
    • pruritus
    • cough
    • infusion rxn
    • febrile neutropenia
    • malaise
    • weakness
    • dry mouth
    • somnolence
    • constipation
    • headache
    • mucosal inflammation
    • stomatitis
    • HTN

    Treanda: Safety Monitoring

    Pregnancy: D
    Lactation: Unsafe
    Avoid Pregnancy: use reliable contraception during tx and x3mo after D/C in women of childbearing potential and in men w/ partners of childbearing potential
    Monitoring Parameters: CBC w/ diff, Plt frequently; blood chemistries incl. K, uric acid

    Treanda: Pharmacology

    Metabolism: hydrolysis primarily, liver; CYP450: 1A2 substrate
    Excretion: feces (90%); Half-life: 40min
    Class: Alkylating Agents
    Mechanism Of Action
    alkylates and crosslinks DNA (nitrogen mustard)

    Treanda: Manufacturer/Pricing

     
    Manufacturer: Cephalon, Inc.
    DEA/FDA: Rx

    Treanda: Patient Education

    Patient education material for this drug is not currently available.

    Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides.

    The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Treanda: Pill Pictures

    This information is currently unavailable or not applicable for this drug.

     


    Copyright 1996-2006 Cerner Multum, Inc. Version: 5.05. Revision Date: 10/09/2007
    Last Updated: 10/09/2007


Subscribe to the "News" RSS Feed RSS

  ۞



 

About Us   |  Privacy Policy   |  Terms of Use   |  Contact Us  

© 2012 RxDrug News 1999-2016. All rights reserved